SUPER-CHARGING THE IMMUNE SYSTEM TO FIGHT CANCER
Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and Seoul-based ToolGen Inc.
Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and Seoul-based ToolGen Inc.
https://www.eurekalert.org/pub_releases/2018-12/uoc–nci120418.php
In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs
Cancer immunotherapy — efforts to better arm a patient’s own immune system to attack tumors — has shown great potential for treating some […]
Sydney Morning Herald (By Esther Han)
19 December 2018 — 12:00am
A revolutionary cancer therapy that supercharges a patient’s immune cells to hunt and destroy cancer cells has been approved for use in Australia, ushering in a new era in medicine.
Desperate patients with aggressive blood cancers who have not responded to conventional treatments have been heading […]
An interview with UK immunologist Daniel Davis on national Public Radio’s “Fresh Air” is a good discussion about his new book for a general audience.
November 26, 20181:51 PM ET Heard on Fresh Air
Immunologist Daniel Davis says scientists are harnessing the power of the immune system to create new medications […]
IMMUNOLOGIST Jacques Miller did not win this year’s Nobel Prize in Physiology or Medicine. He didn’t win it last year or the year before that. In fact, the French-born Australian has […]
Health Minister Greg Hunt promotes the prospects for immunotherapy on The Today Show 12 October 2018
‘The Nobel Assembly at Karolinska Institutet has today decided to award the 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation’.
Read the summary in the link NOBEL medicine2018 release
29 May 2018, Hudson Institute of Medical Research
‘Off-the-shelf’ immunotherapies to fight aggressive forms of cancer, including relapsed ovarian and gastric cancers, are being developed in Clayton, Melbourne, thanks to almost $3 million in Federal Government funding awarded to lead participant Cartherics Pty Ltd.
‘Off the shelf cancer hope as rare cell becomes tumour buster’